Current diagnostic criteria for pre-eclampsia include organic dysfunctions. Recognizing predictive signs of complications in the initial clinical evaluation could optimize resources guiding care ...strategies.
To describe the status of pre-eclampsia patients in the initial evaluation by clinical and laboratorial parameters.
Retrospective study approved by Ethics Committee. Location: Guilherme Álvaro Hospital, Santos, São Paulo/Brazil; (May 2017 - April 2018). Inclusion: 85 patients. with pre-ecampsia, according to NHBPEP (2000) criteria. Analized Variables: Gestational age and severe admission complications, pressure values, symptomatology (visual, headache, epigastralgia) and medication use. For the sample’s information, numerical means and descriptive measures were used.
The means of gestational age was 31.7 weeks, systolic and diastolic blood pressures 137.51 and 83.34 mmHg respectively and weight 91.67 kg. 18,8% of urine dipsticks tests were negative or trace. The symptomathic evaluation, 11.8% was visuals (scotoma), 21.2% headache and 12.9% epigastric pain. For medication, 23.5% used Acetylsalicylic acid (ASA), 89.4% methyldopa and 28.2% corticosteroid. About 1.2% of the patients presented placental abruption, 1.2% eclampsia and 5.9% thrombocytopenia as severe complications at admission. No fetal or maternal death occurred in the current analyzed population.
Early clinical evaluation may demonstrate the potential risk of prematurity associated with pre-eclampsia, once the mean of gestacional week was 31 weeks. A considerable fraction of the analyzed women presented obesity and serious clinicals expressions of pre-eclampsia, although approximately 20% was not recognized by the initial proteinuria test screening. An expressive amount of the patients used ASA, without a characterization about the use. Most patients used at least one hypotensive agent, which could be an exaggerated expectation for these drugs. Although just a few patients presented serious complications these risks should not be neglected, mainly the thrombocytopenia. We also observed that some clinical-laboratory data can guide actions since the admission of the pregnant woman.
Preeclampsia (PE) causes morbidity and mortality in several women in the productive phase, including definitive sequels. Recognizing the socio-demographic profile of pregnant women may justify the ...allocation of resources to promote an effective care for this population.
To describe the socio-demographic profile of pregnant women diagnosed with preeclampsia.
Retrospective study of medical records of 98 patients. Place: Hospital Guilherme Álvaro Santos/ Brazil, (from May 2017 to April 2018). Variables analyzed: Previous history of systemic arterial hypertension (SAH) and preeclampsia, first-degree relative with SAH, recreational drug use, cohabitation with the partner, pre-eclampsia, employment status, years of schooling, average number of pregnancies and body mass index (BMI). For all the information in the sample, a description of the data was made through numerical means and descriptive measures of variables with the intention of searching for clues about the behavior of the phenomena studied. The study has ethical approval.
We identified that 53.1% had previous SAH; 29% reported a history of preeclampsia; 83% had first-degree relative with SAH; 19% used recreational drugs; 32% lived with partner; 38% were unemployed. How many means: the time of schooling was of 10,23 years; that of pregnancies of 2.27 previous; and the BMI of 31.93 (obesity).
These data suggest that it is necessary to create strategies for reproductive planning access for this population because several women were in the third gestation and advised of the risks identified in their own history as relatives with SAH. Avoiding additional complications due to drug use, especially among obese women, hypertensive and with a history of pre-eclampsia and that these guidelines need to be reinforced also by low education. These aspects can be recognized by the anamnesis itself, which can optimize resources and optimize financial resources.
Laboratory abnormalities and obesity may be associated with perinatal outcomes in patients with pre-eclampsia. Analysis of these factors may guide damage prevention strategies.
To associate ...laboratory variables and maternal body mass index (BMI) with childbirth outcome before 34 and 37 weeks and perinatal outcomes in cases of pre-eclampsia.
Cohort study. Location: Guilherme Álvaro Hospital, Santos/Brazil; (May/2017–April/ 2018). Inclusion: women with pre-eclampsia (NHBPEP; 2000) and preterm delivery. Group 1: delivery < 34 weeks. Group 2: childbirth < 37 weeks. Measured at admission: uric acid (> 6 mg/dl), liver enzymes (AST> 34 U/I and ALT> 35 U/I), obesity (BMI> 30), neonatal ICU admission. Statistical analysis: Fisher’s exact test (significance p < 0.05). The work has ethical approval.
Sample size: 90 patients. Group 1: AST elevation in 53.3% of the pacients (p = 0.001); ALT elevation in 46.7% (p = 0.001), uric acid elevation in 28.6% (p = 0.068) and 12.5% were obese (p = 0.044). Group 2: AST elevation in 30.2% of the pacients (p = 0.001); ALT elevation in 23.3% (p = 0.004); uric acid elevation in 20% (p = 0.085) and 24.4% were obese (p = 0.047). Of the total sample, 45.6% of newborns were admitted to the neonatal ICU.
In Group 1, with more severe prematurity, hepatic damage and elevated uricemia were more frequent. In Group 2, obesity was more prevalent, corroborating with the literature (Chaemsaithong P, 2018). The neonatal ICU admission of the total sample was significantly elevated. This behavior of the indirectly recognized target organ damage and lipotoxicity, associated with the severity of prematurity, may represent indicators regarding the higher expression of preeclampsia causing preterm delivery, the need to guide prophylaxis strategies and eventually prognostic counseling. Enlarging the sample may add information.
Introduction The onset of preeclampsia is related to nutritional status. Anthropometric measurements can indicate prognosis and underlie different directions. Objectives To assess the anthropometry ...of preeclampsia patients with and without comorbidities. Methods A transversal study, developed at the Guilherme Álvaro Hospital, located at Santos/Brazil. The anthropometric data from 72 women in the mediate postpartum was collected from January 2015 to May 2016. Inclusion criteria: mothers with PE according to the criteria of NHBPEP (2000). After recruitment and acceptance to participate in the study, the patients signed an informed consent. Data analyzed: body mass index (BMI-kg/m2 ), waist circumference (WC, cm) – with reference to the distance from the last rib to the iliac crest, divided by two, and comorbidities associated: diabetes mellitus (DM) and systemic arterial hypertension (SAH). The frequency was calculated by Fisher’s exact test and comparisons between groups, by the Mann-Whitney test (significance value of p < 0.05). The analysis was performed using Graphpad Prism software, version 5.0. Results In the table are expressed the mean values of BMI and WC after patients have been separated into groups: PE (total), PE + DM, PE + SAH, PE + DM + SAH and PE without comorbidities (pure). There was a significant difference in mean BMI when the groups were compared (PE + DM vs PE without comorbidities, p = 0.038; PE + SH vs PE without comorbidities, p = 0.027, and PE + DM + SAH vs PE without comorbidities, p = 0.012). Regarding the waist circumference values, it was only significant difference when the PE group + DM + SAH was compared with PE group without comorbidity ( p = 0.007). Conclusions It can be concluded that the more comorbidities are associated with PE, more changes are observed in anthropometric parameters. It means that a multidisciplinary team monitoring the anthropometric data of these patients is essential to an early observation of comorbidities development that compromises the health status of patients with PE.
The onset of preeclampsia is related to nutritional status. Anthropometric measurements can indicate prognosis and underlie different directions.
To assess the anthropometry of preeclampsia patients ...with and without comorbidities.
A transversal study, developed at the Guilherme Álvaro Hospital, located at Santos/Brazil. The anthropometric data from 72 women in the mediate postpartum was collected from January 2015 to May 2016. Inclusion criteria: mothers with PE according to the criteria of NHBPEP (2000). After recruitment and acceptance to participate in the study, the patients signed an informed consent. Data analyzed: body mass index (BMI-kg/m2), waist circumference (WC, cm) – with reference to the distance from the last rib to the iliac crest, divided by two, and comorbidities associated: diabetes mellitus (DM) and systemic arterial hypertension (SAH). The frequency was calculated by Fisher’s exact test and comparisons between groups, by the Mann-Whitney test (significance value of p<0.05). The analysis was performed using Graphpad Prism software, version 5.0.
In the table are expressed the mean values of BMI and WC after patients have been separated into groups: PE (total), PE+DM, PE+SAH, PE+DM+SAH and PE without comorbidities (pure). There was a significant difference in mean BMI when the groups were compared (PE+DM vs PE without comorbidities, p=0.038; PE+SH vs PE without comorbidities, p=0.027, and PE+DM+SAH vs PE without comorbidities, p=0.012). Regarding the waist circumference values, it was only significant difference when the PE group+DM+SAH was compared with PE group without comorbidity (p=0.007).
Display omitted
It can be concluded that the more comorbidities are associated with PE, more changes are observed in anthropometric parameters. It means that a multidisciplinary team monitoring the anthropometric data of these patients is essential to an early observation of comorbidities development that compromises the health status of patients with PE.
Introduction The onset of preeclampsia is related to diet. The nutritional status is determined mainly by nutrient intake, if taken in excess or shortage causes disturbance. Objectives To analyze ...daily food intake in pregnancies with and without preeclampsia. Methods A transversal study, case-control, developed at the Guilherme Álvaro Hospital located at Santos/Brazil. Data on the food intake were collected from January 2015 to May 2016, from 157 women (72 cases and 85 controls) in the mediate postpartum. The case group was composed by women with preeclampsia (PE) according to the criteria of NHBPEP (2000) and the control group (C) was enrolled by women without hypertension and/or other comorbidities after vaginal delivery with newborn to term. Exclusion criteria for both groups: diabetes mellitus previously diagnosed as well as collagen diseases, smoking, twin pregnancy and fetal malformations. After recruitment and acceptance to participate in the study, the patients signed an informed consent. To assess food consumption was applied a food frequency questionnaire, including four account options for frequency of consumption: daily, weekly, monthly and never. For this current analysis only the data for daily consumption was considered; the data were expressed as percentages of patients in each group analyzed. Results The table shows the profile of the daily food intake among the groups C and PE. Although the values found were similar between both groups, there was lower intake of protein foods (meat, eggs, viscera), as well as fruits, tubers and roots among PE group when compared do the control group. It was also noted in the PE group the lower daily consumption of natural juices. Conclusions Applying a simple questionnaire to assess food frequency, showed that patients in the PE group had lower intake of proteic food. The PE group showed higher consumption canned food and coffee and lower ingestion of natural juice.This could lead to impairment of nutritional status.
The onset of preeclampsia is related to diet. The nutritional status is determined mainly by nutrient intake, if taken in excess or shortage causes disturbance.
To analyze daily food intake in ...pregnancies with and without preeclampsia.
A transversal study, case-control, developed at the Guilherme Álvaro Hospital located at Santos/Brazil. Data on the food intake were collected from January 2015 to May 2016, from 157 women (72 cases and 85 controls) in the mediate postpartum. The case group was composed by women with preeclampsia (PE) according to the criteria of NHBPEP (2000) and the control group (C) was enrolled by women without hypertension and/or other comorbidities after vaginal delivery with newborn to term. Exclusion criteria for both groups: diabetes mellitus previously diagnosed as well as collagen diseases, smoking, twin pregnancy and fetal malformations. After recruitment and acceptance to participate in the study, the patients signed an informed consent. To assess food consumption was applied a food frequency questionnaire, including four account options for frequency of consumption: daily, weekly, monthly and never. For this current analysis only the data for daily consumption was considered; the data were expressed as percentages of patients in each group analyzed.
The table shows the profile of the daily food intake among the groups C and PE. Although the values found were similar between both groups, there was lower intake of protein foods (meat, eggs, viscera), as well as fruits, tubers and roots among PE group when compared do the control group. It was also noted in the PE group the lower daily consumption of natural juices. Display omitted
Applying a simple questionnaire to assess food frequency, showed that patients in the PE group had lower intake of proteic food. The PE group showed higher consumption canned food and coffee and lower ingestion of natural juice.This could lead to impairment of nutritional status.
